ShangPharma Innovation | Robert Wild, Ph.D.
15873
team_member-template-default,single,single-team_member,postid-15873,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,qode-content-sidebar-responsive,qode-theme-ver-10.1.1,builder-parallax-scrolling-active,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

Robert Wild, Ph.D.

Dr. Wild, based in San Diego, CA, is a seasoned R&D executive with almost 20 years of broad biotech/pharma industry experience in drug discovery and development, spanning both small molecules and biologics. He currently advises a number of biotechnology and pharmaceutical companies and investors. Dr. Wild has contributed to the advancement of numerous clinical development candidates, including four FDA-approved oncology therapeutics. Dr. Wild previously served as CSO and Senior VP Research at Ignyta; CSO Oncology Research at Eli Lilly; Senior Director at OSI (Astellas); and as a Senior Research Investigator at Bristol-Myers Squibb and Sugen. He received his undergraduate and graduate degrees at the University of Minnesota.

d
c